CRON

+ Watchlist + Portfolio

Cronos Group Inc.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $3.29
52-Week Range: $2.28 – $3.43
Market Cap: $1.19B
P/E (TTM): 16.95
EPS (TTM): 0.19
Dividend Yield: —

Advanced Metrics

Price/Book: 1.12
PEG Ratio: —
Return on Equity: 7.05%
Return on Assets: -0.10%
Gross Margin: 43.02%
Operating Margin: 15.44%
Profit Margin: 39.08%
Current Ratio: 16.18
Debt/Equity: 0.00
Total Debt: $1.29M
Free Cash Flow: $6.11M
Revenue Growth: 58.40%
Earnings Growth: —
Enterprise Value: $439.34M

CRON Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$86.75M	$87.24M	$117.61M	$146.59M
Cost of Revenue	$71.31M	$75.33M	$92.42M	$83.83M
Gross Profit	$15.44M	$11.91M	$25.20M	$62.76M
Research & Development	$13.13M	$5.84M	$4.23M	$4.45M
Selling, General & Admin	$100.73M	$80.93M	$76.82M	$70.81M
Operating Expenses	$119.83M	$91.82M	$84.75M	$82.26M
Operating Income	-$104.39M	-$79.91M	-$59.55M	-$19.50M
EBITDA	-$91.27M	-$71.80M	-$50.21M	-$5.27M
Pretax Income	-$121.00M	-$73.67M	$36.59M	-$17.12M
Income Tax	$34.17M	-$3.23M	-$3.44M	-$14.19M
Net Income	-$168.73M	-$73.96M	$41.08M	-$9.45M
Diluted EPS	-0.45	-0.19	0.11	-0.02
Diluted Shares	376.96M	380.96M	385.56M	383.47M

CRON Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$764.64M	$669.29M	$858.80M	$791.79M
Receivables	$37.77M	$35.88M	$29.77M	$57.20M
Inventory	$37.56M	$30.50M	$33.15M	$46.75M
Current Assets	$960.16M	$933.31M	$936.11M	$944.09M
Total Assets	$1.21B	$1.14B	$1.17B	$1.20B
Current Liabilities	$68.12M	$41.40M	$49.70M	$48.19M
Total Debt	$3.88M	$2.55M	$2.02M	$1.51M
Total Liabilities	$72.05M	$44.14M	$55.33M	$54.18M
Retained Earnings	$490.68M	$416.72M	$457.71M	$447.76M
Shareholders' Equity	$1.14B	$1.10B	$1.06B	$1.09B
Working Capital	$892.04M	$891.91M	$886.41M	$895.90M

CRON Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	-$88.95M	-$42.84M	$18.84M	$25.87M
Capital Expenditure	-$5.03M	-$3.42M	-$13.15M	-$26.06M
Free Cash Flow	-$93.98M	-$46.26M	$5.69M	-$190.00K
Depreciation & Amortisation	$13.12M	$8.11M	$9.34M	$14.23M
Stock-Based Compensation	$15.12M	$8.77M	$8.70M	$7.05M
Investing Cash Flow	-$1.84M	-$59.50M	$175.15M	-$76.56M
Financing Cash Flow	-$2.90M	-$1.03M	-$1.23M	-$19.91M
Share Repurchases	—	$0.00	$0.00	-$9.74M
Net Change in Cash	-$93.69M	-$103.36M	$192.76M	-$70.60M

CRON Income statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Revenue	$32.26M	$33.45M	$36.34M	$44.53M	$45.21M
Cost of Revenue	$18.53M	$18.95M	$18.01M	$28.34M	$26.06M
Gross Profit	$13.73M	$14.50M	$18.33M	$16.19M	$19.15M
Research & Development	$793.00K	$929.00K	$1.34M	$1.38M	$1.41M
Selling, General & Admin	$15.96M	$17.26M	$16.89M	$20.70M	$18.66M
Operating Expenses	$17.25M	$19.06M	$23.36M	$22.59M	$20.61M
Operating Income	-$3.52M	-$4.56M	-$5.03M	-$6.40M	-$1.46M
EBITDA	-$677.00K	-$354.00K	-$1.49M	-$2.74M	$2.27M
Pretax Income	$7.27M	-$39.01M	$27.00M	-$12.39M	$18.14M
Income Tax	-$455.00K	-$525.00K	-$1.32M	-$11.89M	$2.43M
Net Income	$6.12M	-$39.71M	$25.96M	-$1.82M	$13.75M
Diluted EPS	0.02	-0.10	0.07	0.00	0.04
Diluted Shares	306.10M	385.31M	384.99M	382.53M	343.80M

CRON Balance Sheet statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Cash & Equivalents	$797.82M	$794.42M	$784.17M	$791.79M	$821.86M
Receivables	$31.76M	$39.38M	$38.17M	$57.20M	$52.37M
Inventory	$34.60M	$42.14M	$48.17M	$46.75M	$48.68M
Current Assets	$918.58M	$927.15M	$922.15M	$944.09M	$927.88M
Total Assets	$1.15B	$1.18B	$1.18B	$1.20B	$1.17B
Current Liabilities	$33.05M	$37.61M	$41.07M	$48.19M	$42.42M
Total Debt	$1.82M	$2.01M	$1.74M	$1.51M	$1.31M
Total Liabilities	$39.06M	$45.02M	$46.36M	$54.18M	$48.30M
Retained Earnings	$463.82M	$424.08M	$450.03M	$447.76M	$460.54M
Shareholders' Equity	$1.07B	$1.08B	$1.08B	$1.09B	$1.07B
Working Capital	$885.53M	$889.53M	$881.08M	$895.90M	$885.46M

CRON Cash Flow statement, quarterly periods, in USD
USD	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026
Operating Cash Flow	-$2.10M	$2.82M	$13.31M	$11.84M	$10.90M
Capital Expenditure	-$15.36M	-$3.84M	-$4.59M	-$2.27M	-$1.97M
Free Cash Flow	-$17.45M	-$1.02M	$8.72M	$9.56M	$8.93M
Depreciation & Amortisation	$2.84M	$4.20M	$3.53M	$3.66M	$3.73M
Stock-Based Compensation	$2.09M	$1.38M	$2.33M	$1.25M	$1.31M
Investing Cash Flow	-$55.36M	-$983.00K	-$23.00M	$2.78M	$38.03M
Financing Cash Flow	-$2.93M	-$7.69M	-$1.87M	-$7.42M	-$18.27M
Share Repurchases	$0.00	-$3.61M	-$1.86M	-$4.27M	-$16.73M
Net Change in Cash	-$60.38M	-$5.85M	-$11.56M	$7.19M	$30.66M

Market Snapshot

About

Cronos Group Inc. is a global cannabinoid company that cultivates, manufactures, and markets cannabis products. Headquartered in Toronto, Canada, the company operates through subsidiaries in Canada, the United States, Israel, and Colombia. Cronos produces and distributes dried cannabis, cannabis oils, and cannabis-based products for both medical and adult-use markets. The company has strategic partnerships including a significant investment from Altria Group and collaborations focused on cannabinoid research and product development.